![Terry Pearson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Terry Pearson
Hoofd Techniek/Wetenschap/O&O bij Siscapa Assay Technologies, Inc.
Actieve functies van Terry Pearson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Science Council of British Columbia | Directeur/Bestuurslid | 01-09-2010 | - |
CAVA Healthcare, Inc.
![]() CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | Directeur/Bestuurslid | - | - |
Siscapa Assay Technologies, Inc.
![]() Siscapa Assay Technologies, Inc. BiotechnologyHealth Technology Siscapa Assay Technologies, Inc. provides products and services for precise quantitation of protein biomarkers, drugs, and drug targets using immuno-affinity mass spectrometry. Siscapa assays are used in clinical diagnostics and pharma R&D for particularly demanding applications, and in biomarker panels to characterize changes in health, disease, and treatment in longitudinal user-collected dried blood microsamples. Siscapa immuno-affinity mass spectrometry assays for targeted protein quantitation can be developed more quickly than typical ELISA immunoassays since they require only a single specific antibody and provide absolute target specificity because of the MS detection. Because Siscapa assays do not interact with one another, these assays can be freely assembled in panels for various applications. The American company was founded by N. Leigh Anderson, who has been the CEO since incorporation. | Hoofd Techniek/Wetenschap/O&O | - | - |
Eyam Vaccines & Immunotherapeutics Ltd. | Directeur/Bestuurslid | 10-01-2022 | - |
Loopbaan van Terry Pearson
Eerdere bekende functies van Terry Pearson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BIOASIS TECHNOLOGIES INC. | Directeur/Bestuurslid | 27-03-2008 | 21-09-2017 |
Independent Dir/Board Member | 27-03-2008 | 21-09-2017 | |
MARKER THERAPEUTICS, INC. | Directeur/Bestuurslid | - | 05-12-2005 |
University of British Columbia | Corporate Officer/Principal | - | - |
NEVIS BRANDS INC. | Directeur/Bestuurslid | 16-12-2014 | - |
Independent Dir/Board Member | 16-12-2014 | - | |
University of Victoria | Corporate Officer/Principal | 01-01-1979 | - |
░░░ ░░░░░ ░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Opleiding van Terry Pearson
University of British Columbia | Doctorate Degree |
Statistieken
Internationaal
Canada | 7 |
Verenigde Staten | 5 |
Operationeel
Director/Board Member | 7 |
Independent Dir/Board Member | 2 |
Corporate Officer/Principal | 2 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Consumer Non-Durables | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
MARKER THERAPEUTICS, INC. | Health Technology |
BIOASIS TECHNOLOGIES INC. | Health Technology |
NEVIS BRANDS INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Siscapa Assay Technologies, Inc.
![]() Siscapa Assay Technologies, Inc. BiotechnologyHealth Technology Siscapa Assay Technologies, Inc. provides products and services for precise quantitation of protein biomarkers, drugs, and drug targets using immuno-affinity mass spectrometry. Siscapa assays are used in clinical diagnostics and pharma R&D for particularly demanding applications, and in biomarker panels to characterize changes in health, disease, and treatment in longitudinal user-collected dried blood microsamples. Siscapa immuno-affinity mass spectrometry assays for targeted protein quantitation can be developed more quickly than typical ELISA immunoassays since they require only a single specific antibody and provide absolute target specificity because of the MS detection. Because Siscapa assays do not interact with one another, these assays can be freely assembled in panels for various applications. The American company was founded by N. Leigh Anderson, who has been the CEO since incorporation. | Health Technology |
CAVA Healthcare, Inc.
![]() CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | Consumer Non-Durables |
The Terry Fox Foundation | |
Science Council of British Columbia | |
Eyam Vaccines & Immunotherapeutics Ltd. |
- Beurs
- Insiders
- Terry Pearson
- Ervaring